companydata.dkcompanydata.dk

XELLIA PHARMACEUTICALS ApS: Financial statements 2016

CVR: 61094628

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

XELLIA PHARMACEUTICALS ApS (CVR 61094628) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 1,475,168,000 and a net result of DKK 33,769,000 compared with DKK -74,009,000 the year before. That is an increase of 21.3% compared with the year before. The profit margin was 2.3%. Equity in the 2016 report amounted to DKK 758,845,000. The solvency ratio was 31.5%. The company had 466 employees in the financial year.

Revenue
DKK 1,475,168,000
Gross Profit
DKK 521,830,000
Profit/Loss
DKK 33,769,000
Equity
DKK 758,845,000
Total Assets
DKK 2,406,944,000
Employees
466

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20161.5B521.8M33.8M758.8M466
20151.2B364.2M-74M729.2M479

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like XELLIA PHARMACEUTICALS ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

XELLIA PHARMACEUTICALS ApS: The 2015 annual report is outMay 22, 2016

XELLIA PHARMACEUTICALS ApS has published its annual report for 2015. Revenue came to DKK 1,215,664,000, and the net result was DKK -74,009,000.

Lars Mosberg joins the board of XELLIA PHARMACEUTICALS ApSFeb 9, 2016

As of February 9, 2016, Lars Mosberg has joined the board of directors of XELLIA PHARMACEUTICALS ApS.

Susanne Lisby leaves the board of XELLIA PHARMACEUTICALS ApSFeb 9, 2016

As of February 9, 2016, Susanne Lisby has left the board of directors of XELLIA PHARMACEUTICALS ApS.

About XELLIA PHARMACEUTICALS ApS

XELLIA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København S, founded in 1959. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named AXELLIA PHARMACEUTICALS ApS and ALPHARMA ApS. The management consists of Michael Kocher. The board consists of Søren Hostrup (chair), Alexander Sebastian Benjamin Sproedt, Hugo Mendes Marques Crespo Dos Reis and Lars Beck Madsen. The company is owned by XELLIA GROUP ApS. The company has 461 employees (2026). In 2025, the company reported revenue of DKK 1,461,516,000 and a net result of DKK 213,738,000 compared with DKK 828,966,000 the year before. Equity in the 2025 report amounted to DKK 404,569,000.

Source: annual report 2025, Danish Business Authority